Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Quantum Computing and the Future of Personalized Medicine: An Umbrella Review and the QBIM Model [Series 5, Topic 97]

Juan Moisés de la Serna

Published Apr 2, 2026• 0 citations
Publisher

Abstract

High-rigor Umbrella Review (v7.0) on the role of quantum computing in drug discovery and molecular simulation
DOI
10.5281/zenodo.19385075

Related papers

AI and Quantum Computing for Accelerating Drug Discovery and Precision Medicine

Kavitha K. S., J. Kamalakumari, Gopal Krishna +2 more

This chapter will present how AI and Quantum Computing together can synergistically take the process of drug discovery and precision medicine to the next level. With AI possessing such powerful processing and analytic capabilities for large datasets, this enables the identification of novel drug candidates and optimization of clinical trial processes. Quantum Computing, with its unimaginable computational power, will be in a position to model such complex molecular interactions with much better accuracy in predicting the efficacy of drugs than any other classical approach. They work in collaboration to reduce timelines for drug development, slash costs drastically, and provide personalized treatment to the given individual's genetic, environment, and lifestyle factors. This chapter undertakes a review of the current applications, future trends, and challenges arising from integrating AI and Quantum Computing into pharmaceutical and healthcare industries because of their transformational impact on the future of medicine.

Advances in computer and electrical engineering book series•Dec 13, 2024•5 citations

AI & Quantum Computing: Emerging Paradigms in Biomedical Research & Personalized Medicine

Prashant Kumar Tiwari, Alia Siddiqui, Ritu Khosla

•Jan 1, 2025•0 citations

Quantum Computing in Drug Discovery Techniques, Challenges, and Emerging Opportunities

Gomase VS, Arjun P. Ghatule, Rupali Sharma +1 more

INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.

Current Drug Discovery Technologies•Sep 1, 2025•6 citations

Proposition on Quantum Computing Applications in Drug Discovery and Development

Lennex Annor, Atif Mohammad

Communications in computer and information science•Sep 2, 2026•0 citations

Quantum Computing in Biopharma: Redefining Molecular Design and Predictive Pharmacology

Pravin Puri, Prashant Kardile, Shyam Manza

The convergence of quantum computing (QC) and biopharmaceutical science promises to revolutionize molecular design and predictive pharmacology. Quantum computing — harnessing principles of superposition, entanglement and quantum algorithms — enables simulation of molecular interactions with a precision and scale beyond the reach of classical methods. This review outlines the fundamental principles of QC, discusses current applications in drug discovery and pharmacology, highlights hybrid quantum-classical approaches and quantum-machine learning (QML), and examines the challenges and future directions. The review suggests that, though currently at a nascent stage, QC could dramatically reduce drug development timelines, improve success rates, and pave the way for personalized medicine and complex biologics design.

•Dec 16, 2025•0 citations

Role of quantum computing in accelerating drug discovery process

Nirmala Ganesan, R. Rahul, S. Sibi Sidharth

Elsevier eBooks•Jan 1, 2025•2 citations
This chapter will present how AI and Quantum Computing together can synergistically take the process of drug discovery and precision medicine to the next level. With AI possessing such powerful processing and analytic capabilities for large datasets, this enables the identification of novel drug candidates and optimization of clinical trial processes. Quantum Computing, with its unimaginable computational power, will be in a position to model such complex molecular interactions with much better accuracy in predicting the efficacy of drugs than any other classical approach. They work in collaboration to reduce timelines for drug development, slash costs drastically, and provide personalized treatment to the given individual's genetic, environment, and lifestyle factors. This chapter undertakes a review of the current applications, future trends, and challenges arising from integrating AI and Quantum Computing into pharmaceutical and healthcare industries because of their transformational impact on the future of medicine.
INTRODUCTION: Quantum computing represents a transformative advancement in computational science, with applications in drug discovery, molecular interaction simulation, drug-target binding optimization, and the analysis of complex biological data at unprecedented speeds and accuracy. Quantum computing emerges as a powerful tool to accelerate the development of new therapeutics, drug design, and the simulation of complex chemical interactions, including personalized medicine strategies. The objective of this study is to explore the potential of quantum computing in drug discovery and development, highlighting its ability to reduce time and costs while accelerating the identification of promising drug candidates. METHODS: Quantum computing algorithms, such as Grover's algorithm and the Variational Quantum Eigensolver (VQE), are utilized to simulate molecular interactions of drugs and optimize drug design. In case studies, such as IBM's use of VQE for molecular simulations, these technologies demonstrate their effectiveness. RESULTS: Quantum computing has shown promise in addressing several technological barriers, such as lengthy development timelines and high costs. Additionally, demonstrated success in molecular simulations and solving challenges during the drug development process. However, challenges related to error rates, qubit coherence, and regulatory compliance remain. DISCUSSION: This study examines the applications of quantum computing in drug discovery, highlighting key techniques such as quantum simulation, quantum machine learning, and optimization algorithms. Quantum computing is crucial for interdisciplinary collaboration among quantum physicists, computational chemists, biologists, and pharmaceutical professionals, as it is essential to overcoming these obstacles and realizing the full potential of quantum technologies in medicine. CONCLUSION: Quantum computing holds great potential in drug discovery and development, offering accelerated, more accurate, and lower-cost research avenues, particularly in complex areas such as protein folding prediction and personalized medicine. This new paradigm has tremendous potential for guiding the future of pharmaceutical development and patient-focused medicine.
The convergence of quantum computing (QC) and biopharmaceutical science promises to revolutionize molecular design and predictive pharmacology. Quantum computing — harnessing principles of superposition, entanglement and quantum algorithms — enables simulation of molecular interactions with a precision and scale beyond the reach of classical methods. This review outlines the fundamental principles of QC, discusses current applications in drug discovery and pharmacology, highlights hybrid quantum-classical approaches and quantum-machine learning (QML), and examines the challenges and future directions. The review suggests that, though currently at a nascent stage, QC could dramatically reduce drug development timelines, improve success rates, and pave the way for personalized medicine and complex biologics design.